Get the Stockscreener App
1.60
3.23%
0.05
After Hours:
1.59
-0.01
-0.63%
Metagenomi Inc stock is traded at $1.60, with a volume of 461.02K.
It is up +3.23% in the last 24 hours and up +8.11% over the past month.
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
See More
Previous Close:
$1.55
Open:
$1.58
24h Volume:
461.02K
Relative Volume:
1.13
Market Cap:
$58.69M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+10.73%
1M Performance:
+8.11%
6M Performance:
-24.17%
1Y Performance:
-75.57%
1-Day Range:
$1.535
$1.61
1-Week Range:
$1.40
$1.6494
52-Week Range:
$1.23
$8.1747
Metagenomi Inc Stock (MGX) Company Profile
Name
Metagenomi Inc
Sector
Industry
Phone
(510) 871-4880
Address
5959 HORTON STREET, EMERYVILLE
Compare MGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.60 | 58.69M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.00 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.16 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
542.47 | 37.56B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.86 | 35.18B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
224.73 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Initiated | H.C. Wainwright | Buy |
| May-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-05-24 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-24 | Initiated | Chardan Capital Markets | Buy |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Mar-05-24 | Initiated | Jefferies | Buy |
| Mar-05-24 | Initiated | TD Cowen | Outperform |
| Mar-05-24 | Initiated | Wells Fargo | Overweight |
View All
Metagenomi Inc Stock (MGX) Latest News
Metagenomi: Q1 Earnings Snapshot - San Francisco Chronicle
Metagenomi reports Q1 EPS (68c), consensus (51c) - TipRanks
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results - GlobeNewswire
Metagenomi (MGX) and Its Competitors Head-To-Head Review - Defense World
Metagenomi (MGX) Projected to Post Earnings on Tuesday - Defense World
Metagenomi, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsMGX - ACCESS Newswire
Metagenomi, Inc. (MGX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Wells Fargo & Company MN Increases Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Renaissance Technologies LLC Has $555,000 Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
JPMorgan Chase & Co. Acquires 65,020 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Inc [MGX] stock for 1,744 USD was sold by Wein Matthew - knoxdaily.com
Metagenomi Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Market Update: Metagenomi Inc (MGX) Sees Negative Movement, Closing at 1.49 - DWinneX
Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
Metagenomi Inc (NASDAQ: MGX)’s -10.37-Percent Loss Of This Past Week Taught Us Something New - Marketing Sentinel
Geode Capital Management LLC Has $2.12 Million Stock Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MGX - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Metagenomi, Inc.(MGX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Metagenomi (MGX) versus Its Competitors Critical Analysis - Defense World
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
Corebridge Financial Inc. Grows Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Metagenomi, Inc. - marketscreener.com
Sei Investments Co. Acquires New Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Prudential Financial Inc. - Defense World
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Can you still get a good price for Metagenomi Inc (MGX) Shares at this point? - uspostnews.com
Metagenomi Inc Stock (MGX) Financials Data
There is no financial data for Metagenomi Inc (MGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metagenomi Inc Stock (MGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wapnick Pamela | Chief Financial Officer |
Mar 05 '25 |
Sale |
1.87 |
1,808 |
3,390 |
59,684 |
| Wapnick Pamela | Chief Financial Officer |
Dec 05 '24 |
Sale |
1.86 |
1,559 |
2,900 |
61,492 |
| Wapnick Pamela | Chief Financial Officer |
Sep 05 '24 |
Sale |
2.88 |
6,265 |
18,043 |
63,051 |
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):